Literature DB >> 7947790

Three-dimensional structure of chymotrypsin inactivated with (2S)-N-acetyl-L-alanyl-L-phenylalanyl alpha-chloroethane: implications for the mechanism of inactivation of serine proteases by chloroketones.

K Kreutter1, A C Steinmetz, T C Liang, M Prorok, R H Abeles, D Ringe.   

Abstract

The reaction of enantiomerically pure (2S)-N-acetyl-L-alanyl-L-phenylalanyl alpha-chloroethane with gamma-chymotrypsin was studied as a probe of the mechanism of inactivation of serine proteases by peptidyl chloroalkanes. It was determined crystallographically that the peptidyl chloroethane alkylates His57 with retention of configuration at the chiral center, indicating a double displacement mechanism. We think it likely that a Ser195-epoxy ether adduct is an intermediate on the inactivation pathway, although other possibilities have not been disproven. Kinetic data reported by others [Angliker et al. (1988) Biochem. J. 256, 481-486] indicate that the epoxy ether intermediate is not an irreversibly inactivated form of enzyme [a conclusion confirmed experimentally (Prorok et al. (1994) Biochemistry 33, 9784-9790)] and that both ring closure of the tetrahedral intermediate to form the epoxy ether and ring opening by His57 partially limit the first-order rate constant for inactivation, ki. The peptidyl chloroethyl derivative adopts a very different active site conformation from that assumed by serine proteases inactivated by peptidyl chloromethanes. Positioning the chloroethyl derivative into the conformation adopted by chloromethyl derivatives would cause the extra methyl group to make a bad van der Waals contact with the inactivator P2 carbonyl carbon, thereby preventing the formation of the invariant hydrogen bond between the inactivator P1 amide nitrogen and the carbonyl group of Ser214. We conclude that the unusual conformation displayed by the chloroethyl derivative is caused by steric hindrance between the extra methyl group and the rest of the inactivator chain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7947790     DOI: 10.1021/bi00250a033

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Another biological effect of tosylphenylalanylchloromethane (TPCK): it prevents p47phox phosphorylation and translocation upon neutrophil stimulation.

Authors:  Maggaly Gillibert; Zakia Dehry; Micheline Terrier; Jamel El Benna; Florence Lederer
Journal:  Biochem J       Date:  2005-03-15       Impact factor: 3.857

2.  Haloenol lactones as inactivators and substrates of aldehyde dehydrogenase.

Authors:  N Mukerjee; M Dryjanski; W Dai; J A Katzenellenbogen; R Pietruszko
Journal:  J Protein Chem       Date:  1996-10

3.  Haloacetamidine-based inactivators of protein arginine deiminase 4 (PAD4): evidence that general acid catalysis promotes efficient inactivation.

Authors:  Bryan Knuckley; Corey P Causey; Perry J Pellechia; Paul F Cook; Paul R Thompson
Journal:  Chembiochem       Date:  2010-01-25       Impact factor: 3.164

4.  Structure-function analyses of human kallikrein-related peptidase 2 establish the 99-loop as master regulator of activity.

Authors:  Wolfgang Skala; Daniel T Utzschneider; Viktor Magdolen; Mekdes Debela; Shihui Guo; Charles S Craik; Hans Brandstetter; Peter Goettig
Journal:  J Biol Chem       Date:  2014-10-16       Impact factor: 5.157

5.  An episulfide cation (thiiranium ring) trapped in the active site of HAV 3C proteinase inactivated by peptide-based ketone inhibitors.

Authors:  Jiang Yin; Maia M Cherney; Ernst M Bergmann; Jianmin Zhang; Carly Huitema; Hanna Pettersson; Lindsay D Eltis; John C Vederas; Michael N G James
Journal:  J Mol Biol       Date:  2006-07-07       Impact factor: 5.469

6.  A mechanistic view of enzyme inhibition and peptide hydrolysis in the active site of the SARS-CoV 3C-like peptidase.

Authors:  Jiang Yin; Chunying Niu; Maia M Cherney; Jianmin Zhang; Carly Huitema; Lindsay D Eltis; John C Vederas; Michael N G James
Journal:  J Mol Biol       Date:  2007-06-08       Impact factor: 5.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.